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Apolipoprotein A-I Restores Endothelial Function in Rats with Arthritis 
Ben J. Wu, Sudichhya Shrestha, Yue Li, Kwok L. Ong, Philip J. Barter and Kerry-Anne Rye 
Centre for Vascular Research, University of New South Wales, Sydney, NSW, Australia  
 
Introduction. Endothelial dysfunction is a key event in the development of atherosclerosis and has been 
identified in patients with rheumatoid arthritis and in rats with experimental arthritis. We have recently 
shown that apolipoprotein A-I (apoA-I), the most abundant apolipoprotein in high density lipoproteins 
(HDL), and reconstituted HDL [(A-I)rHDL] consisting of apoA-I complexed with phosphatidylcholine inhibit 
streptococcal cell wall peptidoglycan-polysaccharide (PG-PS)-induced arthritis in female Lewis rats.  
Aim. This study asks if apoA-I also improves endothelial dysfunction in rats with arthritis.  
Methods and Results. A single intraperitoneal injection of PG-PS (15 mg/kg) or an equivalent volume of 
saline (control) was administered to female Lewis rats. After four days the PG-PS-treated animals had 
acute joint inflammation, elevated circulating inflammatory cytokine levels, and had aortic endothelial 
dysfunction. Intravenous infusions of lipid-free apoA-I (8 mg/kg) 24 h pre- and 24 h post-PG-PS 
administration decreased the acute joint inflammation, reduced plasma TNF- , IL-6 and IL-1ȕ levels, and 
restored aortic endothelial function with an improvement in aortic vasorelaxation and an increase in 
guanosine 3’,5’-cyclic monophosphate (cGMP) production at day 4 post-PG-PS injection. In ex vivo 
studies, incubation of aortic rings from control female Lewis rats with TNF-Į (10 ng/mL) for 6 h impaired 
aortic vasorelaxation and decreased cGMP production. Pre-incubation of the aortic rings for 16 h with (A-
I)rHDL (final apoA-I concentration 0.5 and 1.0 mg/mL) improved the TNF- -induced impaired aortic 
vasorelaxation, and cGMP production. In addition, (A-I)rHDL induced endothelial nitric oxide synthase 
(eNOS) expression in human coronary artery endothelial cells (HCAECs) in a time- and dose-dependent 
manner. Incubation of HCAECs with TNF-Į (1 ng/mL) for 6 h reduced HCAEC eNOS expression. Pre-
incubation of the HCAECs for 16 h with (A-I)rHDL restored the TNF-  reduced HCAEC eNOS expression.  
Discussion. These findings establish that apoA-I improves endothelial dysfunction in rats with arthritis by, 
at least partly, inhibiting inflammatory cytokine induced endothelial dysfunction.   
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Introduction. Thymoquinone causes an endothelium-dependent augmentation of contraction in isolated 
arteries, similar to that evoked by hypoxia.  
Aims. Ex vivo experiments were designed to study the mechanisms underlying this unexpected response. 
Methods. Arterial rings with or without endothelium were suspended in organ chambers for isometric 
tension recording. Certain rings were incubated with inhibitors of nitric oxide synthase (L-NAME, 10-4 M), 
soluble guanylyl cyclase (sGC; ODQ, 10-5 M), rho-associated protein kinases (Y-27632, 10-5 M), L-type- 
(nifedipine, 10-5 M) or T-type voltage-gated calcium channels (ML-218, 10-4 M), while others were 
calcium-depleted (n=4-7). The rings were contracted with phenylephrine (10-6 M, rat aortae) or 
prostaglandin F2Į (10-7 – 10-5 M, porcine coronary arteries) and exposed to increasing concentrations of 
thymoquinone. Some rings were used to measure cyclic nucleotide level by HPLC-MS/MS (n=4-6). 
Results. Thymoquinone caused a sustained further increase of tension in rings with endothelium, which 
was prevented by endothelium-removal, L-NAME and ODQ. Incubation with the NO-donor DETA 
NONOate (10-5 M) in L-NAME-treated rings restored and even increased the contractile response to 
thymoquinone, while treatment with 8-bromo cyclic GMP (10-4 M) or pyrophosphate (10-3 M) of ODQ-
treated rings did not. HPLC-MS/MS measurements revealed that thymoquinone increased the production 
of cyclic IMP. Y-27632, nifedipine and calcium depletion inhibited the thymoquinone-induced contraction 
in porcine but not in rat arteries, while ML-218 reduced the phenomenon in rat but not in porcine arteries. 
Discussion. The augmentation caused by thymoquinone requires endothelium-derived NO and activation 
of sGC, as described for hypoxia. In addition, both thymoquinone- and hypoxia-induced augmentation 
require production of cyclic IMP, altering intracellular calcium handling.  
Thymoquinone can serve as a pharmacological tool to elicit endothelium-dependent vasoconstrictions 
that require activation of soluble guanylyl cyclase. 
